ECSP056091A - Proceso para la preparacion del analogo de ciclosporina a - Google Patents

Proceso para la preparacion del analogo de ciclosporina a

Info

Publication number
ECSP056091A
ECSP056091A EC2005006091A ECSP056091A ECSP056091A EC SP056091 A ECSP056091 A EC SP056091A EC 2005006091 A EC2005006091 A EC 2005006091A EC SP056091 A ECSP056091 A EC SP056091A EC SP056091 A ECSP056091 A EC SP056091A
Authority
EC
Ecuador
Prior art keywords
preparation
cyclosporin
cyclosporine analog
analogue
formula
Prior art date
Application number
EC2005006091A
Other languages
English (en)
Inventor
Jean-Michel Adam
Mark Abel
Seetharaman Jayaraman
Original Assignee
Isotechnika Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isotechnika Inc filed Critical Isotechnika Inc
Publication of ECSP056091A publication Critical patent/ECSP056091A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links
    • C07K7/645Cyclosporins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/12Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Transplantation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

El presente invento se relaciona con un nuevo proceso para la preparación de análogo de la ciclosporina A de la formula I: que comprende los pasos de, a) alicatar un aldehído protegido de ciclosporina A con un reactivo alilmetálico y, b) transformar el compuesto obtenido en el paso a) al análogo de la ciclosporina A de la fórmula I.
EC2005006091A 2003-04-08 2005-10-07 Proceso para la preparacion del analogo de ciclosporina a ECSP056091A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03007921 2003-04-08

Publications (1)

Publication Number Publication Date
ECSP056091A true ECSP056091A (es) 2006-03-01

Family

ID=33155122

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2005006091A ECSP056091A (es) 2003-04-08 2005-10-07 Proceso para la preparacion del analogo de ciclosporina a

Country Status (18)

Country Link
US (1) US20040220091A1 (es)
EP (1) EP1613646A2 (es)
JP (1) JP2006525961A (es)
KR (1) KR20050119200A (es)
CN (1) CN1798759A (es)
AU (1) AU2004228159A1 (es)
BR (1) BRPI0409734A (es)
CA (1) CA2521116A1 (es)
CO (1) CO5680450A2 (es)
EC (1) ECSP056091A (es)
MA (1) MA27831A1 (es)
MX (1) MXPA05010794A (es)
NO (1) NO20054478L (es)
RU (1) RU2005130508A (es)
TN (1) TNSN05255A1 (es)
TW (1) TW200505946A (es)
WO (1) WO2004089960A2 (es)
ZA (1) ZA200507980B (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6859799B1 (en) 1998-11-30 2005-02-22 Gemstar Development Corporation Search engine for video and graphics
US7103906B1 (en) 2000-09-29 2006-09-05 International Business Machines Corporation User controlled multi-device media-on-demand system
BRPI0114571B1 (pt) 2000-10-11 2016-11-08 Rovi Guides Inc sistemas e métodos para proporcionar armazenamento de dados em servidores em sistema de expedição de mídia em demanda ou por demanda
US7493646B2 (en) 2003-01-30 2009-02-17 United Video Properties, Inc. Interactive television systems with digital video recording and adjustable reminders
AU2004222306A1 (en) 2003-03-17 2004-09-30 Albany Molecular Research, Inc. Novel cyclosporins
CA2575280C (en) * 2004-07-29 2012-08-14 Amr Technology, Inc. Novel processes for stereoselective synthesis of trans isatx 247
US8086575B2 (en) 2004-09-23 2011-12-27 Rovi Solutions Corporation Methods and apparatus for integrating disparate media formats in a networked media system
JP2008514702A (ja) 2004-09-29 2008-05-08 エーエムアール テクノロジー インコーポレイテッド 新規シクロスポリン類似体およびそれらの薬学的使用
WO2006039163A2 (en) 2004-09-29 2006-04-13 Amr Technology, Inc. Cyclosporin alkyne analogues and their pharmaceutical uses
WO2006041631A2 (en) 2004-10-06 2006-04-20 Amr Technology, Inc. Novel cyclosporin alkynes and their utility as pharmaceutical agents
KR100780718B1 (ko) 2004-12-28 2007-12-26 엘지.필립스 엘시디 주식회사 도포액 공급장치를 구비한 슬릿코터
US8607287B2 (en) 2005-12-29 2013-12-10 United Video Properties, Inc. Interactive media guidance system having multiple devices
US9681105B2 (en) 2005-12-29 2017-06-13 Rovi Guides, Inc. Interactive media guidance system having multiple devices
US7696165B2 (en) 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
US7696166B2 (en) 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
US20090019492A1 (en) 2007-07-11 2009-01-15 United Video Properties, Inc. Systems and methods for mirroring and transcoding media content
AU2008310956B2 (en) 2007-10-08 2014-08-07 Aurinia Pharmaceuticals Inc. Ophthalmic compositions comprising calcineurin inhibitors or mTOR inhibitors
US8601526B2 (en) 2008-06-13 2013-12-03 United Video Properties, Inc. Systems and methods for displaying media content and media guidance information
FR2934997B1 (fr) * 2008-08-14 2010-09-24 Minakem Derives cyclopropyl-et cyclobutyl-dioxazaborocanes ou dioxazaborecanes
MX338355B (es) 2009-06-09 2016-04-13 Aurinia Pharmaceuticals Inc Sistemas de suministro de farmaco topico para uso oftalmico.
US9014546B2 (en) 2009-09-23 2015-04-21 Rovi Guides, Inc. Systems and methods for automatically detecting users within detection regions of media devices
LT2651965T (lt) 2010-12-15 2019-01-10 Contravir Pharmaceuticals, Inc. Ciklosporino analogo molekulės su modifikuotomis 1 ir 3 aminorūgštimis
US8805418B2 (en) 2011-12-23 2014-08-12 United Video Properties, Inc. Methods and systems for performing actions based on location-based rules
AR090964A1 (es) 2012-05-09 2014-12-17 Novartis Ag Proceso para la elaboracion de undecapeptidos ciclicos
US9674563B2 (en) 2013-11-04 2017-06-06 Rovi Guides, Inc. Systems and methods for recommending content
US20190224275A1 (en) 2017-05-12 2019-07-25 Aurinia Pharmaceuticals Inc. Protocol for treatment of lupus nephritis
EP4201952A1 (en) 2021-12-21 2023-06-28 Curia Spain, S.A.U. Process for the controlled synthesis of voclosporin
WO2025119925A1 (en) 2023-12-05 2025-06-12 Medichem, S.A. Process for preparing voclosporin
IT202300028041A1 (it) 2023-12-27 2025-06-27 Indena Spa Processo per la preparazione di voclosporina

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0296122B1 (en) * 1987-06-17 1993-09-29 Sandoz Ag Cyclosporins and their use as pharmaceuticals
WO1998048791A1 (en) * 1997-04-30 1998-11-05 The Regents Of The University Of California Synthesis of discodermolide and analogs
DE69840586D1 (de) * 1997-10-08 2009-04-02 Isotechnika Inc Deuterierte Cyclosporin-analoga und ihre Verwendung als immunmodulierende Agenzien
DE10143979A1 (de) * 2001-09-07 2003-03-27 Clariant Gmbh Verfahren zur Herstellung von Bisallylboranen und nicht-aromatischen Boronsäuren
DK1436322T3 (da) * 2001-10-19 2008-11-03 Isotechnika Inc Blandinger af cyclosporinanaloger og deres anvendelse som immunmodulerende midler
DE60231570D1 (de) * 2001-10-19 2009-04-23 Isotechnika Inc Synthese von Cyclosporinanalogen

Also Published As

Publication number Publication date
CA2521116A1 (en) 2004-10-21
CN1798759A (zh) 2006-07-05
CO5680450A2 (es) 2006-09-29
BRPI0409734A (pt) 2006-05-09
KR20050119200A (ko) 2005-12-20
NO20054478D0 (no) 2005-09-28
AU2004228159A1 (en) 2004-10-21
WO2004089960A3 (en) 2005-01-06
MXPA05010794A (es) 2005-12-14
WO2004089960A2 (en) 2004-10-21
TNSN05255A1 (en) 2007-07-10
NO20054478L (no) 2005-10-17
US20040220091A1 (en) 2004-11-04
ZA200507980B (en) 2006-11-29
RU2005130508A (ru) 2006-06-27
JP2006525961A (ja) 2006-11-16
TW200505946A (en) 2005-02-16
MA27831A1 (fr) 2006-04-03
EP1613646A2 (en) 2006-01-11

Similar Documents

Publication Publication Date Title
ECSP056091A (es) Proceso para la preparacion del analogo de ciclosporina a
BR112012014082A2 (pt) composições e métodos que compreendem variantes de protease
BRPI0520870B8 (pt) compostos intermediários para a preparação de alfa-mercaptoacetanilidas de s-triazolila
ECSP10010245A (es) Peptidil nitrilos y uso de los mismos como inhibidores de dipeptidil peptidasa i
ECSP11010812A (es) Complejo de mineral-aminoácido polisacárido
PY09026846A (es) Composiciones y métodos para anticuerpos que se dirigen a la proteína de complemento c5
ECSP077316A (es) Compuestos imidazo-3-il-amina bicíclicos sustituidos
TW200731094A (en) Extensible meta-data
ECSP099721A (es) Inhibidores de cinasa p70 s6
HN2008001723A (es) Nitrilos espirociclicos como inhibidores de proteasa
UY28745A1 (es) Nuevos compuestos
CR20110240A (es) Inhibidores de cinasa akt y p70 s6
CR11018A (es) Estabilizacion de vitamina b12
CL2012003104A1 (es) Compuestos derivados de multiheteroarilos, inhibidores de prostaglandina d sintasa hematopoyetica (h-pgds); y composicion farmaceutica que los comprende.
ECSP055671A (es) Nuevas quinazolinonas espirocondensadas y su uso como inhibidores de la fosfodiesteresa
BRPI0713031B8 (pt) composto de di-hidro-piran-2-ona, composição farmacêutica, e uso dos mesmos
CR10548A (es) 18-metil-19nor-androst-4-en-17, 17-espiroeteres (18-metil-19-nor-20-espirox-4-en-3-onas) asi como preparaciones farmaceuticas que los contienen
AR064955A1 (es) Composicion y metodo para estabilizar ingredientes sensibles
EA200600590A1 (ru) Фармацевтические композиции модафинила с модифицированным высвобождением
CL2009001342A1 (es) Pregn-4-en-21,17-carbolactonas sustituidas en el anillo c; preparados farmaceuticos que lo contienen; compuesto 11 alfa-hidroxi-15 beta, 16 beta-metilen-androst-4-en-3,17-diona; procedimiento para preparar dicho compuesto que comprende el uso de microorganismos.
BRPI0508102A (pt) inibidores de caspase e usos dos mesmos
HN2006029142A (es) Proceso
ECSP099089A (es) Composiciones farmaceuticas que contienen un anticuerpo monoclonal anti-idiotipico anti-ca-125 y derivados de aluminio
UY30555A1 (es) Formulacion aerosol para la inhalacion de beta-agonistas
GT200600039A (es) Tiazolidinonas, su preparacion y su uso como medicamento